MedMen Enterprises Inc. MMNFF's fiscal third-quarter results saw increased revenue by 22 percent to $36.6 million across operations in California, Nevada, New York, Arizona and Illinois.
MedMen continued to perform favorably in California with $24.9 million in retail revenue and retail gross margins increasing to 57 percent.
MedMen reported its revenue from pending acquisitions and pre-closing revenue from recently closed acquisitions, pro forma quarterly revenue was approximately $57 million.
MedMen decreased corporate selling, general and administrative expense by 9 percent quarter over quarter with a plan to achieve an overall 20 percent reduction from the previous quarter. The company also announced a $250 million financing commitment from Gotham Green Partners.
MedMen's stock traded around $2.37 per share at time of publication.
Related Links:
Cresco Labs Reports Q1 Sales Of $21.1M, Up 313% Year Over Year
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
